/WELL
WELL Stock - Welltower Inc.
Real Estate|REIT - Healthcare FacilitiesNYSE
$186.01-0.79%
$1.48 (-0.79%) • Dec 19
70
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.66
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).75
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.86
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+12.5%upside
Target: $209.26
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for WELL
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$184.15 – $187.87
TARGET (TP)$209.25
STOP LOSS$171.13
RISK/REWARD1:1.6
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.84
52W High$209.05
52W Low$123.11
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $7.85B | $6.48B | $5.78B | $4.71B | $4.59B |
| Gross Profit | $3.02B | $2.53B | $2.22B | $1.93B | $1.99B |
| Gross Margin | 38.5% | 39.1% | 38.4% | 41.1% | 43.4% |
| Operating Income | $1.15B | $940.45M | $746.22M | $763.36M | $727.45M |
| Net Income | $951.68M | $340.09M | $141.21M | $336.14M | $978.84M |
| Net Margin | 12.1% | 5.2% | 2.4% | 7.1% | 21.3% |
| EPS | $1.58 | $0.66 | $0.31 | $0.79 | $2.36 |
Company Overview
Welltower Inc. (NYSE:WELL), an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The Company invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience. Welltower, a real estate investment trust (REIT), owns interests in properties concentrated in major, high-growth markets in the United States, Canada and the United Kingdom, consisting of seniors housing and post-acute communities and outpatient medical properties.
Visit WebsiteRating Distribution
Strong Buy
2
10%
Buy / Outperform
13
65%
Hold / Neutral
5
25%
Sell / Underperform
0%
Analyst Consensus🟢 Bullish
15 Bullish5 Neutral/Bearish
Price Targets
$112
Average Target
↓ 39.6% Downside
Now
$66
Low
$112
Average
$208
High
Based on 30 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 18th 2025 | JP Morgan | Downgrade | Neutral | $205 |
| November 5th 2025 | Evercore ISI | Upgrade | Outperform | $208 |
| October 1st 2025 | Cantor Fitzgerald | Initiation | Overweight | $195 |
| September 19th 2025 | UBS | Initiation | Buy | $195 |
| April 8th 2025 | Wells Fargo | Upgrade | Overweight | $158 |
| February 28th 2025 | RBC Capital Mkts | Upgrade | Outperform | $168← $146 |
| February 14th 2025 | Wedbush | Upgrade | Outperform | $167← $145 |
| January 2nd 2025 | Jefferies | Upgrade | Buy | $147← $132 |
| March 18th 2024 | Exane BNP Paribas | Initiation | Outperform | $104 |
| January 30th 2024 | Deutsche Bank | Initiation | Buy | $115 |
| December 18th 2023 | JP Morgan | Upgrade | Overweight | $99← $92 |
| November 28th 2023 | RBC Capital Mkts | Downgrade | Sector Perform | $97← $92 |
| November 9th 2023 | Raymond James | Upgrade | Strong Buy | $101← $95 |
| October 12th 2023 | JP Morgan | Downgrade | Neutral | $90 |
| October 3rd 2023 | Wedbush | Initiation | Neutral | $83 |
Earnings History & Surprises
WELLBeat Rate
83%
Last 18 quarters
Avg Surprise
+13.1%
EPS vs Estimate
Beats / Misses
15/0
3 met exactly
Latest EPS
$1.34
Q4 2025
EPS Surprise History
Q1 24
+2.1%
$0.96vs$0.94
Q2 24
+7.4%
$1.01vs$0.94
Q3 24
+5.0%
$1.05vs$1.00
Q4 24
+6.7%
$1.11vs$1.04
Q1 25
+182.5%
$1.13vs$0.40
Q2 25
+4.3%
$1.20vs$1.15
Q3 25
+4.9%
$1.28vs$1.22
Q4 25
+3.1%
$1.34vs$1.30
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 27, 2026 | — | — | — | — |
Q1 2026 | Feb 10, 2026 | $1.42 | — | — | — |
Q4 2025 | Oct 27, 2025 | $1.30 | $1.34 | +3.1% | ✓ BEAT |
Q3 2025 | Jul 28, 2025 | $1.22 | $1.28 | +4.9% | ✓ BEAT |
Q2 2025 | Apr 28, 2025 | $1.15 | $1.20 | +4.3% | ✓ BEAT |
Q1 2025 | Feb 11, 2025 | $0.40 | $1.13 | +182.5% | ✓ BEAT |
Q4 2024 | Oct 28, 2024 | $1.04 | $1.11 | +6.7% | ✓ BEAT |
Q3 2024 | Jul 29, 2024 | $1.00 | $1.05 | +5.0% | ✓ BEAT |
Q2 2024 | Apr 29, 2024 | $0.94 | $1.01 | +7.4% | ✓ BEAT |
Q1 2024 | Feb 13, 2024 | $0.94 | $0.96 | +2.1% | ✓ BEAT |
Q4 2023 | Oct 30, 2023 | $0.89 | $0.92 | +3.4% | ✓ BEAT |
Q3 2023 | Jul 31, 2023 | $0.86 | $0.90 | +4.7% | ✓ BEAT |
Q2 2023 | May 2, 2023 | $0.82 | $0.85 | +3.7% | ✓ BEAT |
Q1 2023 | Feb 15, 2023 | $0.82 | $0.83 | +1.2% | ✓ BEAT |
Q4 2022 | Nov 7, 2022 | $0.84 | $0.84 | 0.0% | = MET |
Q3 2022 | Aug 9, 2022 | $0.85 | $0.86 | +1.2% | ✓ BEAT |
Q2 2022 | May 10, 2022 | $0.82 | $0.82 | 0.0% | = MET |
Q1 2022 | Feb 15, 2022 | $0.81 | $0.83 | +2.5% | ✓ BEAT |
Q4 2021 | Nov 4, 2021 | $0.80 | $0.80 | 0.0% | = MET |
Q3 2021 | Jul 29, 2021 | $0.77 | $0.79 | +2.6% | ✓ BEAT |
Latest News
JP Morgan Downgrades Welltower to Neutral, Announces $205 Price Target
➖ NeutralBenzinga•Dec 18, 2025, 01:35 PM
UBS Maintains Buy on Welltower, Raises Price Target to $232
📈 PositiveBenzinga•Dec 4, 2025, 05:09 PM•Also:
Wells Fargo Maintains Overweight on Welltower, Raises Price Target to $218
📈 PositiveBenzinga•Nov 25, 2025, 05:08 PM•Also:
CNBC Halftime Report Final Trades: Welltower, Starbucks , Alphabet Class A
➖ NeutralBenzinga•Nov 20, 2025, 06:01 PM•Also: , ,
Morgan Stanley Maintains Overweight on Welltower, Raises Price Target to $200
📈 PositiveBenzinga•Nov 20, 2025, 03:48 PM
Scotiabank Maintains Sector Outperform on Welltower, Raises Price Target to $214
📈 PositiveBenzinga•Nov 13, 2025, 06:18 PM
Live On CNBC, Josh Brown Hosts Segment Titled "Best Stocks In The Market: Welltower; Ventas "
📈 PositiveBenzinga•Nov 7, 2025, 05:40 PM•Also:
CNBC Halftime Report Final Trades: Welltower, Microsoft, iShares U.S. Consumer Discretionary ETF, Dell Technologies
➖ NeutralBenzinga•Nov 5, 2025, 06:01 PM•Also: ,
Evercore ISI Group Upgrades Welltower to Outperform, Raises Price Target to $208
📈 PositiveBenzinga•Nov 5, 2025, 11:52 AM
Cantor Fitzgerald Maintains Overweight on Welltower, Raises Price Target to $200
📈 PositiveBenzinga•Oct 31, 2025, 01:28 PM
UBS Maintains Buy on Welltower, Raises Price Target to $203
📈 PositiveBenzinga•Oct 29, 2025, 03:37 PM•Also:
Welltower Files For Offer And Resale By Selling Stockholder Of Up To 1,182,070 Shares Of Common Stock
➖ NeutralBenzinga•Oct 28, 2025, 01:54 PM
Welltower Files For Offering Of Up To $7.5B Of Common Stock
➖ NeutralBenzinga•Oct 28, 2025, 01:52 PM
Welltower Announces $23B In Transactions To Expand Its Focus On Rental Housing For Seniors, Including $14B In Acquisitions Of High-Quality U.S. And U.K. Communities
📈 PositiveBenzinga•Oct 27, 2025, 08:12 PM
Welltower Raises FY2025 FFO Guidance from $5.06-$5.14 to $5.24-$5.30 vs $5.11 Est
📈 PositiveBenzinga•Oct 27, 2025, 08:08 PM
Welltower Q3 FFO $1.34 Beats $1.30 Estimate, Sales $2.686B Beat $2.586B Estimate
📈 PositiveBenzinga•Oct 27, 2025, 08:07 PM
Wells Fargo Maintains Overweight on Welltower, Raises Price Target to $200
📈 PositiveBenzinga•Oct 21, 2025, 01:25 PM
Scotiabank Maintains Sector Outperform on Welltower, Raises Price Target to $182
📈 PositiveBenzinga•Oct 6, 2025, 03:08 PM
Cantor Fitzgerald Initiates Coverage On Welltower with Overweight Rating, Announces Price Target of $195
📈 PositiveBenzinga•Oct 1, 2025, 02:14 PM
Keybanc Maintains Overweight on Welltower, Raises Price Target to $200
📈 PositiveBenzinga•Sep 23, 2025, 01:08 PM
Frequently Asked Questions about WELL
What is WELL's current stock price?
Welltower Inc. (WELL) is currently trading at $186.01 per share. The stock has moved -0.79% today.
What is the analyst price target for WELL?
The average analyst price target for WELL is $209.25, based on 1 analyst.
What sector is Welltower Inc. in?
Welltower Inc. operates in the Real Estate sector, specifically within the REIT - Healthcare Facilities industry. The company is traded on the NYSE exchange.
What is WELL's market cap?
Welltower Inc. has a market capitalization of $127.66 billion, making it a large-cap company.
Does WELL pay dividends?
No, Welltower Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Real Estate SectorAMT
American Tower Corporation
$172.41
Mkt Cap: $80.7B
DLR
Digital Realty Trust, Inc.
$149.99
Mkt Cap: $51.5B
EQIX
Equinix, Inc.
$758.51
Mkt Cap: $74.0B
GMRE
Global Medical REIT Inc.
$34.17
Mkt Cap: $0.5B
LTC
LTC Properties, Inc.
$34.20
Mkt Cap: $1.6B
NHI
National Health Investors, Inc.
$77.84
Mkt Cap: $3.7B
PLD
Prologis, Inc.
$127.23
Mkt Cap: $118.0B
UHT
Universal Health Realty Income Trust
$41.41
Mkt Cap: $0.6B
VTR
Ventas, Inc.
$79.10
Mkt Cap: $35.0B
Explore stocks similar to WELL for comparison